Lucie Bartova

Vienna, Austria

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 85 publications

Real-world effectiveness and safety of intranasal esketamine for treatment-resistant depression: data from the enTRD registry.

Real-world effectiveness and safety of intranasal esketamine for treatment-resistant depression: data from the enTRD registry.

Journal: European psychiatry : the journal of the Association of European Psychiatrists

Published: June 23, 2026

Trajectory of response to esketamine nasal spray for treatment resistant depression: Findings from ESCAPE-TRD.

Trajectory of response to esketamine nasal spray for treatment resistant depression: Findings from ESCAPE-TRD.

Journal: European psychiatry : the journal of the Association of European Psychiatrists

Published: June 16, 2026

Trajectory of response to esketamine nasal spray for treatment resistant depression: findings from ESCAPE-TRD.

Trajectory of response to esketamine nasal spray for treatment resistant depression: findings from ESCAPE-TRD.

Journal: European psychiatry : the journal of the Association of European Psychiatrists

Published: June 16, 2026

Milnacipran continuation during pregnancy in a patient with severe post-traumatic stress disorder and psychotic depression: a case report with 3-year pediatric follow-up.

Milnacipran continuation during pregnancy in a patient with severe post-traumatic stress disorder and psychotic depression: a case report with 3-year pediatric follow-up.

Journal: Frontiers in psychiatry

Published: March 14, 2026

Continuous infusion [11C]-(+)-PHNO PET for measuring dopamine D2/3 receptor availability and amphetamine effects across the brain: Feasibility and test-retest reliability.

Continuous infusion [11C]-(+)-PHNO PET for measuring dopamine D2/3 receptor availability and amphetamine effects across the brain: Feasibility and test-retest reliability.

Journal: European journal of nuclear medicine and molecular imaging

Published: February 06, 2026

Ketamine for negative and depressive symptoms in schizophrenia: the evidence so far.

Ketamine for negative and depressive symptoms in schizophrenia: the evidence so far.

Journal: Frontiers in psychiatry

Published: December 12, 2025

Use and Perceived Helpfulness of Different Intervention Strategies in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Depression.

Use and Perceived Helpfulness of Different Intervention Strategies in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Depression.

Journal: Journal of clinical medicine

Published: December 03, 2025

Understanding patient-reported outcomes in functional movement disorder: Association with clinical measures and change following integrative treatment.

Understanding patient-reported outcomes in functional movement disorder: Association with clinical measures and change following integrative treatment.

Journal: Journal of psychosomatic research

Published: November 25, 2025

Secondary Restless Legs Syndrome during psychopharmacological treatment: real-world evidence from a multinational pharmacovigilance program.

Secondary Restless Legs Syndrome during psychopharmacological treatment: real-world evidence from a multinational pharmacovigilance program.

Journal: The international journal of neuropsychopharmacology

Published: November 21, 2025

Optimizing Identification and Management of Depression in Neurological Diseases: A Narrative Review and Expert Perspective.

Optimizing Identification and Management of Depression in Neurological Diseases: A Narrative Review and Expert Perspective.

Journal: Neuropsychiatric disease and treatment

Published: October 21, 2025

Symptom networks in major depressive disorder and treatment response: special focus on TRD.

Symptom networks in major depressive disorder and treatment response: special focus on TRD.

Journal: European psychiatry : the journal of the Association of European Psychiatrists

Published: May 27, 2025

Clinical predictors of treatment resistant depression.

Clinical predictors of treatment resistant depression.

Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology

Published: April 04, 2025

Showing 1-12 of 85

Last Updated: 09/26/2026